Assistant Professor, PhD Supervisor
Research Interests: pharmacoepidemiology, real-world study of medical product
Tel: +86-10-82805019
Email: xuyang_pucri@bjmu.edu.cn
EDUCATION
Doctor of Philosophy, Peking University (2018)
Master of Clinical Pharmacy, Peking University (2015)
Bachelor of Economics, Peking University (2013)
Bachelor of Science, Peking University (2013)
PROFESSIONAL AFFILIATIONS
2023 - present Peking University, School of Pharmaceutical Sciences, Department of Pharmacy Administration and Clinical Pharmacy, Assistant professor
ACADEMIC APPOINTMENTS
Center for Medical Device Evaluation, National Medical Products Administration, Specialist (2025)
Beijing Research Association for Chronic Diseases Control and Health Education, Member (2025)
Journal of Intensive Medicine, Statistical Editor (2024)
AWARDS AND CERTIFICATES
Karolinska Institutet, Special grants for younger scientists (2024)
60th European Renal Association Congress, Best Abstract (2023)
REPRESENTATIVE PUBLICATIONS (2023-2025)
1. Xu Y*, Huang T, Zhang Y, Ji D, Tuttle KR, Carrero JJ, Fu EL. Risk of heart failure hospitalization for GLP-1 receptor agonists vs. DPP-4 inhibitors or SGLT-2 inhibitors in patients with type 2 diabetes: a target trial emulation. Circulation. (in press.) (JCR Q1)
2.Lai Y, Her QL, Zhang Y, Xu H, Kucharska-Newton A, Ji D, Wu G, Garden G, Stürmer T, Wang T*, Xu Y*. The heterogeneous treatment effects of statins on dementia: a target trial emulation with causal machine learning using integrated genetic and real-world data. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. (in press.) (JCR Q1)
3.Guo J, Wang T, Liu Z, Zeng W, Shen P, Sun Y, Zhan S*, Xu Y*. Estimating cardiovascular effects of influenza vaccination in older adults: a target trial emulation using proximal causal inference. EClinicalMedicine. 2025 Aug 21;87:103449. (JCR Q1)
4.Su G, Xiao R, Ji D, He K, Hallert A, Savarese G, Lund LH, Xu Y*, Carrero JJ. Diagnostic work-up of anemia and associated health outcomes in people with heart failure. BMC Medicine. 2025 Aug 12;23(1):471. (JCR Q1)
5.Zeng W, Wang T, Stürmer T, He N, Shen P, Lin H, Guan X, Xu Y*. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study. Cardiovascular Diabetology. 2025 May 6;24(1):194. (JCR Q1)
6.Bai Z, Li C, Lai Y, Hu X, Shi L, Guan X*, Xu Y*. Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis. Antibiotics (Basel). 2025 Mar 10;14(3):287. (JCR Q1)
7.Guo J, Wang T, Cao H, Ma Q, Tang Y, Li T, Wang L, Xu Y*, Zhan S*. Application of methodological strategies to address unmeasured confounding in real-world vaccine safety and effectiveness study: a systematic review. Journal of Clinical Epidemiology. 2025 May;181:111737. (JCR Q1)
8.Ji D, Dong S, Wang T, Wei J, Shen P, Lin H, Shi L, Guan X*, Xu Y*. Statin Use and Risk of Intracerebral Hemorrhage in Chinese Population: A Target Trial Emulation Study. Neurology. 2025 Apr 22;104(8):e213489. (JCR Q1)
9.Lu B#, Xu Y#, Li N, Zhou Y, Ma X, Chen Y, Dong R, Zhou X, Dai M, Chen H, Weng L*, Du B*; China National Critical Care Quality Control Center Group and China Critical Care Clinical Trials Group (CCCCTG). Overall and geographic pattern of incidence, fatality and mortality of sepsis among hospitalized non-child cancer patients in China: A nationwide cross-sectional study. Science Bulletin. 2024 Jun 15;69(11):1637-1641. (JCR Q1)
10.Xu Y, Wang YF, Liu YW, Dong R, Chen Y, Wang Y, Weng L, Du B; China Critical Care Clinical Trials Group (CCCCTG) and China National Critical Care Quality Control Center Group. The Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis. Critical Care Medicine. 2024 Nov 1;52(11):1739-1749. (JCR Q1)
11.Huang T, Bosi A, Faucon AL, Grams ME, Sjölander A, Fu EL, Xu Y*, Carrero JJ. GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes. JAMA Internal Medicine. 2024 Oct 1;184(10):1195-1203. (JCR Q1)
12.Xu H, Eriksdotter M, Garcia-Ptacek S, Ferreira D, Ji D, Bruchfeld A, Xu Y*, Carrero JJ. Acute Kidney Injury and Its Association With Dementia and Specific Dementia Types: Findings From a Population-Based Study in Sweden. Neurology. 2024 Sep 24;103(6):e209751. (JCR Q1)
13.Wang T, Ji D, Stürmer T, Ismail S, Dong S, Shen P, Lin H, Shi L, Guan X, Xu Y*. The effect of sodium glucose cotransporter-2 inhibitors on hemoglobin A1c variability and acute kidney injury: a causal mediation analysis. Pharmacoepidemiology and Drug Safety. 2024 Aug;33(8):e5876. (JCR Q3)
14.Liu Y, Wang Y, Chen Y, Dong R, Li S, Peng J, Liufu R, Weng L*, Xu Y*, Du B. A nationwide study on new onset atrial fibrillation risk factors and its association with hospital mortality in sepsis patients. Scientific Reports. 2024 May 28;14(1):12206. (JCR Q1)
15.Xu Y*, Evans M, Mazhar F, et al. Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care. Journal of Internal Medicine. 2023;00:1-12. (JCR Q1)
16.Xu Y*, Dong S, Fu EL, Sjölander A, Grams ME, Selvin E, Carrero JJ: Long-term visit-to-visit variability in hemoglobin A(1c) and kidney-related outcomes in persons with diabetes. American journal of kidney diseases. 2023;82(3):254-256. (JCR Q1)
17.Weng L#, Xu Y#, Yin P#, Wang Y, Chen Y, Liu W, Li S, Peng JM, Dong R, Hu XY, Jiang W, Wang CY, Gao P, Zhou MG, Du B and for the China Critical Care Clinical Trials G. National incidence and mortality of hospitalized sepsis in China. Critical Care. 2023;27:84. (JCR Q1)